Does previous valve replacement affect short-term coronary artery bypass grafting outcomes? A population-based National Inpatient Sample study from 2015 to 2020.

IF 2.5 3区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Journal of cardiology Pub Date : 2024-08-16 DOI:10.1016/j.jjcc.2024.08.005
Renxi Li, Stephen J Huddleston, Deyanira J Prastein
{"title":"Does previous valve replacement affect short-term coronary artery bypass grafting outcomes? A population-based National Inpatient Sample study from 2015 to 2020.","authors":"Renxi Li, Stephen J Huddleston, Deyanira J Prastein","doi":"10.1016/j.jjcc.2024.08.005","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Coronary artery disease (CAD) and valvular disease frequently coexist due to similar pathophysiology. Effort has been dedicated to comprehending the outcomes of concomitant coronary revascularization and valve replacement procedures. However, the understanding of how prior valve replacement affects the outcomes of coronary artery bypass grafting (CABG) remains limited. Thus, this study aimed to conduct a population-based examination of the in-hospital outcomes in patients with previous valve replacement in CABG.</p><p><strong>Methods: </strong>Patients who underwent CABG were identified in the National Inpatient Sample in the USA from Q4 2015-2020. Patients with age < 18 years and concomitant procedures were excluded. A 1:3 propensity-score matching was used to address differences in demographics, socioeconomic status, primary payer status, hospital characteristics, comorbidities, and transfer/admission status between patients with and without previous valve replacement. In-hospital postoperative outcomes were assessed.</p><p><strong>Results: </strong>There were 514 patients with previous valve replacement who underwent CABG, who were matched to 1588 out of 167,668 controls. After matching, patients with valve replacement had mostly comparable in-hospital outcomes except for a higher risk of vascular complications (1.75 % vs 0.57 %, p = 0.02), a longer length of stay (10.90 ± 7.04 days vs 9.95 ± 6.53 days, p = 0.01), and higher hospital charges (275,465 ± 229,088 US dollars vs 231,648 ± 189,938 US dollars, p < 0.01).</p><p><strong>Conclusion: </strong>For short-term outcomes, CABG is generally safe for patients who have undergone previous valve replacement, although there is an increased risk of vascular complications that may warrant additional attention. The findings of this study can be valuable for preoperative risk assessment of patients who have had valve replacement and are considering CABG.</p>","PeriodicalId":15223,"journal":{"name":"Journal of cardiology","volume":null,"pages":null},"PeriodicalIF":2.5000,"publicationDate":"2024-08-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of cardiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.jjcc.2024.08.005","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Coronary artery disease (CAD) and valvular disease frequently coexist due to similar pathophysiology. Effort has been dedicated to comprehending the outcomes of concomitant coronary revascularization and valve replacement procedures. However, the understanding of how prior valve replacement affects the outcomes of coronary artery bypass grafting (CABG) remains limited. Thus, this study aimed to conduct a population-based examination of the in-hospital outcomes in patients with previous valve replacement in CABG.

Methods: Patients who underwent CABG were identified in the National Inpatient Sample in the USA from Q4 2015-2020. Patients with age < 18 years and concomitant procedures were excluded. A 1:3 propensity-score matching was used to address differences in demographics, socioeconomic status, primary payer status, hospital characteristics, comorbidities, and transfer/admission status between patients with and without previous valve replacement. In-hospital postoperative outcomes were assessed.

Results: There were 514 patients with previous valve replacement who underwent CABG, who were matched to 1588 out of 167,668 controls. After matching, patients with valve replacement had mostly comparable in-hospital outcomes except for a higher risk of vascular complications (1.75 % vs 0.57 %, p = 0.02), a longer length of stay (10.90 ± 7.04 days vs 9.95 ± 6.53 days, p = 0.01), and higher hospital charges (275,465 ± 229,088 US dollars vs 231,648 ± 189,938 US dollars, p < 0.01).

Conclusion: For short-term outcomes, CABG is generally safe for patients who have undergone previous valve replacement, although there is an increased risk of vascular complications that may warrant additional attention. The findings of this study can be valuable for preoperative risk assessment of patients who have had valve replacement and are considering CABG.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
既往瓣膜置换术会影响冠状动脉旁路移植术的短期疗效吗?一项基于人群的 2015-2020 年全国住院患者样本研究。
背景:冠状动脉疾病(CAD)和瓣膜疾病由于相似的病理生理学而经常并存。人们一直致力于了解同时进行冠状动脉血运重建和瓣膜置换术的结果。然而,人们对先前的瓣膜置换术如何影响冠状动脉旁路移植术(CABG)疗效的了解仍然有限。因此,本研究旨在对既往接受过瓣膜置换术的冠状动脉旁路移植术患者的院内预后进行基于人群的研究:方法:从 2015-2020 年第四季度的美国全国住院患者样本中确定接受过 CABG 的患者。患者年龄 结果在 167,668 名对照者中,有 514 名曾接受过瓣膜置换术的患者与 1588 名曾接受过瓣膜置换术的患者进行了匹配。匹配后,除了血管并发症风险更高(1.75 % vs 0.57 %,p = 0.02)、住院时间更长(10.90 ± 7.04 天 vs 9.95 ± 6.53 天,p = 0.01)和住院费用更高(275,465 ± 229,088 美元 vs 231,648 ± 189,938 美元,p 结论:就短期疗效而言,CABG 和 CABG 的疗效更接近:就短期疗效而言,接受过瓣膜置换术的患者接受 CABG 一般是安全的,但血管并发症的风险增加,可能需要额外注意。本研究的结果对曾接受过瓣膜置换术并考虑接受 CABG 的患者进行术前风险评估很有价值。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Journal of cardiology
Journal of cardiology CARDIAC & CARDIOVASCULAR SYSTEMS-
CiteScore
4.90
自引率
8.00%
发文量
202
审稿时长
29 days
期刊介绍: The official journal of the Japanese College of Cardiology is an international, English language, peer-reviewed journal publishing the latest findings in cardiovascular medicine. Journal of Cardiology (JC) aims to publish the highest-quality material covering original basic and clinical research on all aspects of cardiovascular disease. Topics covered include ischemic heart disease, cardiomyopathy, valvular heart disease, vascular disease, hypertension, arrhythmia, congenital heart disease, pharmacological and non-pharmacological treatment, new diagnostic techniques, and cardiovascular imaging. JC also publishes a selection of review articles, clinical trials, short communications, and important messages and letters to the editor.
期刊最新文献
Associations of adipose tissue depots with cardiac resynchronization therapy response and clinical outcomes: A CRT-HF Clinic substudy. Association between complementary use of Goreisan (a Japanese herbal Kampo medicine) and heart failure readmission: A Nationwide propensity score-matched study. Clinical Characteristics and Short-Term Outcomes in Patients With Cardiogenic Shock Undergoing Mechanical Circulatory Support Escalation From Intra-Aortic Balloon Pump to Impella: From the J-PVAD Registry. The role of left atrium posterior wall isolation in patients undergoing catheter ablation for atrial fibrillation. Impact of Diabetes Mellitus on Post-CABG Outcomes in Veterans: Insights from the REGROUP Trial.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1